Pharmacy Practice in Focus: Health Systems
Editor-in-Chief
Curtis E. Haas, PharmD, FCCP
Chief Pharmacy Officer, University of Rochester Medical Center
Chief Pharmacy Officer, University of Rochester Medical Center
Associate Editor
Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP
Assistant Professor of Clinical Pharmacy,
Division of Clinical Pharmacy,
Division of the Black Diaspora and African American Studies,
Skaggs School of Pharmacy and Pharmaceutical Sciences,
University of California San Diego
Director of Education, COPE Health Equity Collaborative
Adjunct Assistant Professor,
Department of Basic Sciences,
Loma Linda University School of Medicine
Research Mentor, Loma Linda University Infectious Diseases Pharmacotherapy Fellowship
Assistant Professor of Clinical Pharmacy,
Division of Clinical Pharmacy,
Division of the Black Diaspora and African American Studies,
Skaggs School of Pharmacy and Pharmaceutical Sciences,
University of California San Diego
Director of Education, COPE Health Equity Collaborative
Adjunct Assistant Professor,
Department of Basic Sciences,
Loma Linda University School of Medicine
Research Mentor, Loma Linda University Infectious Diseases Pharmacotherapy Fellowship
Editorial Advisory Boards
Lakesha M. Butler, PharmD
Strategic Engagement and Chief Culture Officer, UF Health
Associate Vice President, Organizational Culture and Clinical Professor, Pharmacotherapy and Translational Research, University of Florida
Strategic Engagement and Chief Culture Officer, UF Health
Associate Vice President, Organizational Culture and Clinical Professor, Pharmacotherapy and Translational Research, University of Florida
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
3
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
4
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
5






